Adverse interaction between beta-adrenergic blocking drugs and verapamil--report of three cases
- PMID: 6127992
- DOI: 10.1111/j.1445-5994.1982.tb03813.x
Adverse interaction between beta-adrenergic blocking drugs and verapamil--report of three cases
Abstract
Three patients with ischaemic heart disease developed profound cardiac failure, hypotension and bradycardia during combined therapy with verapamil and beta-adrenergic blocking drugs. This clinical picture resolved completely with cessation of the combined therapy. Baseline left ventricular function, assessed by cardiac catheterisation or nuclear angiography, was normal in two patients and only mildly reduced in the other. Simultaneously administration of beta-adrenergic blocking drugs and verapamil may result in profound adverse interactions and should only be administered with great caution.
Similar articles
-
Profound sinus bradycardia due to diltiazem, verapamil, and/or beta-adrenergic blocking drugs.J La State Med Soc. 2004 Nov-Dec;156(6):327-31. J La State Med Soc. 2004. PMID: 15688675
-
Clinical significance and predisposing factors to symptomatic bradycardia and hypotension after percutaneous transluminal coronary angioplasty.Am J Cardiol. 1994 Dec 1;74(11):1085-8. doi: 10.1016/0002-9149(94)90456-1. Am J Cardiol. 1994. PMID: 7977063
-
Probable adverse interaction between oral metoprolol and verapamil.Postgrad Med J. 1984 Oct;60(708):705-6. doi: 10.1136/pgmj.60.708.705. Postgrad Med J. 1984. PMID: 6494097 Free PMC article.
-
Beta-adrenoceptor blocking drugs: adverse reactions and drug interactions.Pharmacol Ther. 1983;21(3):351-69. doi: 10.1016/0163-7258(83)90060-8. Pharmacol Ther. 1983. PMID: 6138787 Review.
-
Adverse reactions to beta-adrenergic receptor blocking drugs: a report from the Boston collaborative drug surveillance program.Drugs. 1974;7(1):118-29. doi: 10.2165/00003495-197407010-00008. Drugs. 1974. PMID: 4151696 Review. No abstract available.
Cited by
-
Extent and pharmacokinetic mechanisms of oral atenolol-verapamil interaction in man.Eur J Clin Pharmacol. 1988;35(4):363-6. doi: 10.1007/BF00561365. Eur J Clin Pharmacol. 1988. PMID: 3197744
-
Adverse effects using combined rate-slowing antihypertensive agents.J Clin Hypertens (Greenwich). 2011 Jul;13(7):529-32. doi: 10.1111/j.1751-7176.2011.00486.x. Epub 2011 Jun 20. J Clin Hypertens (Greenwich). 2011. PMID: 21762367 Free PMC article. No abstract available.
-
Calcium channel antagonism and beta blockade in combination--a therapeutic alternative in cardiovascular disorders. A review.Cardiovasc Drugs Ther. 1989 Jun;3(3):355-73. doi: 10.1007/BF01858108. Cardiovasc Drugs Ther. 1989. PMID: 2577284 Review.
-
Beta blockers and verapamil: a cautionary tale.Br Med J (Clin Res Ed). 1984 Oct 20;289(6451):1074. doi: 10.1136/bmj.289.6451.1074-b. Br Med J (Clin Res Ed). 1984. PMID: 6148994 Free PMC article. No abstract available.
-
Calcium antagonists. Drug interactions of clinical significance.Drug Saf. 1995 Sep;13(3):157-87. doi: 10.2165/00002018-199513030-00003. Drug Saf. 1995. PMID: 7495502 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources